astra zeneca27 Jul 2020 11:09
so they're paying today 1 billion upfront then 5 billion later for an "experimental" cancer drug to bring it to the market and that hasnt got regulatory milestones yet?!?
how much for the global treatment of covid!
The U.K. drugmaker will pay Daiichi $1 billion upfront to jointly develop and bring to market a cancer therapy in early clinical tests called DS-1062, with as much as $5 billion in additional payments subject to regulatory and sales milestones, the companies said Monday.
The remaining sum will be paid when regulatory and sales milestones are met, the company added.